VU0155041 sodium
VU0155041 sodium is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. VU0155041 has potential for the research of Parkinson's disease (PD).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1259372-69-4
- Fòrmula: C14H14Cl2NNaO3
- Peso molecular:338.16
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
[1]|
mGluR4 693 nM (EC50) |
In Vitro
VU0155041 (10 μM) does not affect NMDA receptor currents in striatal medium spiny neurons[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
VU0155041 (93 nmol, 316 nmol; i.c.v.) reverses Reserpine (HY-N0480) -induced akinesia in rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Third ventricle cannulated (TVC) Male Sprague-Dawley rats (225-255 g)[1]
-
Dosage:31, 93 nmol
-
Administration:I.c.v. injection after the the 1.5 mg/kg of haloperidol treatment 2 h
-
Result:Decreased the cataleptic effects of haloperidol, and the effects still presented 30 min after infusion.
Chemical Information
-
No. CAS 1259372-69-4
-
Peso molecular 338.16
-
Fòrmula C14H14Cl2NNaO3
-
SMILES
O=C([C@H](CCCC1)[C@H]1C(O[Na])=O)NC2=CC(Cl)=CC(Cl)=C2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)